Phillips-Medisize speeds Chinese product registration

Phillips-Medisize announced that its plant in China recently registered with the China Food and Drug Administration (CFDA).

CEO Matt Jennings said that "The CFDA facility registration will result in shorter China product registration for western companies that manufacture products in our facility for sale in China, as we are permitted to submit through the quick regional/provincial offices. At the most extreme, this can shorten foreign product registration for sale in China from two years to three to six months."...

Read more